Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.]
Comment on Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential.
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod.
Neuroplasticity and functional recovery in multiple sclerosis.
Cervical dysplasia associated with the use of natalizumab.
Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
Spatial modeling of multiple sclerosis for disease subtype prediction.
Validation survey of the impact of urinary incontinence (IIQ-7) and inventory of distress urogenital (UDI-6) - the short scales - in patients with multiple sclerosis.
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.
The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Depression in multiple sclerosis: A long-term longitudinal study.
Distinguishing Susac's syndrome from multiple sclerosis.
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Management of optic neuritis as a clinically first event of multiple sclerosis.
Protection of tregs, suppression of Th1 and th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.

Pages